HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jinhai Fan Selected Research

Prostatic Neoplasms (Prostate Cancer)

10/2018AKR1C3, a crucial androgenic enzyme in prostate cancer, promotes epithelial-mesenchymal transition and metastasis through activating ERK signaling.
11/2016DAB2IP regulates EMT and metastasis of prostate cancer through targeting PROX1 transcription and destabilizing HIF1α protein.
7/20142'-hydroxyflavanone inhibits prostate tumor growth through inactivation of AKT/STAT3 signaling and induction of cell apoptosis.
6/2014Metformin sensitizes prostate cancer cells to radiation through EGFR/p-DNA-PKCS in vitro and in vivo.
8/2013Raman spectroscopy, a potential tool in diagnosis and prognosis of castration-resistant prostate cancer.
6/2010Silibinin reverses epithelial-to-mesenchymal transition in metastatic prostate cancer cells by targeting transcription factors.
9/2006Inhibition of mitogen-elicited signal transduction and growth in prostate cancer with a small peptide derived from the functional domain of DOC-2/DAB2 delivered by a unique vehicle.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jinhai Fan Research Topics

Disease

27Urinary Bladder Neoplasms (Bladder Cancer)
03/2022 - 04/2007
24Neoplasms (Cancer)
03/2022 - 09/2006
13Neoplasm Metastasis (Metastasis)
02/2021 - 06/2010
7Prostatic Neoplasms (Prostate Cancer)
10/2018 - 09/2006
4Non-Muscle Invasive Bladder Neoplasms
01/2022 - 08/2014
4Renal Cell Carcinoma (Grawitz Tumor)
01/2021 - 11/2016
2Carcinoma (Carcinomatosis)
01/2022 - 10/2014
1Breast Neoplasms (Breast Cancer)
03/2022
1Residual Neoplasm
01/2022
1Urinary Bladder Diseases (Bladder Diseases)
06/2019
1Hemorrhage
06/2019
1Mitochondrial Diseases (Mitochondrial Disease)
08/2018
1Hypoxia (Hypoxemia)
03/2018
1Wounds and Injuries (Trauma)
01/2017
1Pain (Aches)
01/2015
1Headache (Headaches)
01/2015
1Adenocarcinoma of Lung
01/2014
1Weight Loss (Weight Reduction)
02/2008

Drug/Important Bio-Agent (IBA)

9Proteins (Proteins, Gene)FDA Link
02/2021 - 09/2006
5Biomarkers (Surrogate Marker)IBA
01/2022 - 12/2015
5AndrogensIBA
10/2018 - 09/2006
4CateninsIBA
04/2020 - 12/2012
4Peptides (Polypeptides)IBA
01/2018 - 09/2006
3Cadherins (E-Cadherin)IBA
10/2018 - 11/2013
3polyarginineIBA
01/2018 - 09/2006
3DNA (Deoxyribonucleic Acid)IBA
06/2014 - 04/2007
2thymoquinoneIBA
04/2020 - 08/2018
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
05/2019 - 11/2016
2ErbB Receptors (EGF Receptor)IBA
05/2019 - 01/2014
2Androgen Receptors (Androgen Receptor)IBA
10/2018 - 11/2016
2VimentinIBA
10/2018 - 03/2018
2Zinc Finger E-box-Binding Homeobox 1IBA
03/2018 - 10/2014
2Contrast MediaIBA
01/2018 - 01/2017
2R11 peptideIBA
01/2018 - 11/2015
2pirarubicinIBA
05/2017 - 12/2015
26-chloro-2-(1-piperazinyl)pyrazine (CPP)IBA
01/2017 - 09/2006
2ras ProteinsIBA
01/2017 - 11/2016
2Matrix Metalloproteinases (MMPs)IBA
08/2015 - 11/2012
2FlavonoidsIBA
07/2014 - 12/2013
22'-hydroxyflavanoneIBA
07/2014 - 03/2014
2Silybin (Lagosa)IBA
12/2013 - 06/2010
2Transcription Factors (Transcription Factor)IBA
11/2013 - 06/2010
2romidepsin (FK228)FDA Link
02/2008 - 04/2007
2Biological ProductsIBA
02/2008 - 09/2006
2Histone Deacetylase InhibitorsIBA
02/2008 - 04/2007
1Syndecan-4IBA
03/2022
1TenascinIBA
03/2022
1toripalimabIBA
01/2022
1Calcium Channels (Calcium Channel)IBA
02/2021
1hydrogen sulfite (bisulfite)IBA
02/2021
1cyclobutanecarbonylcarnitine (CBCC)IBA
07/2020
1Pharmaceutical PreparationsIBA
04/2020
1LigandsIBA
05/2019
1EnzymesIBA
10/2018
1Caspase 12IBA
08/2018
1Endoplasmic Reticulum Chaperone BiPIBA
08/2018
1FITC-annexin A5IBA
08/2018
1Cytochromes c (Cytochrome c)IBA
08/2018
1Small Interfering RNA (siRNA)IBA
03/2018
1Keratin-18 (Keratin 18)IBA
03/2018
1Caspase 3 (Caspase-3)IBA
05/2017
1ferric oxide (iron oxide)IBA
01/2017
1isothiocyanic acidIBA
01/2017
1Fluorescein-5-isothiocyanate (FITC)IBA
01/2017
1Fluorescein (Funduscein)FDA LinkGeneric
01/2017
1Cell-Penetrating PeptidesIBA
01/2017
1Factor V (Coagulation Factor V)IBA
02/2016
1Member 1 Subfamily B ATP Binding Cassette TransporterIBA
12/2015
1MetalsIBA
08/2015
1Ointments (Pastes)IBA
01/2015
1Nitroglycerin (Dynamite)FDA LinkGeneric
01/2015
1Prilocaine Drug Combination LidocaineFDA LinkGeneric
01/2015
1Analgesics (Analgesic Drugs)IBA
01/2015
1Therapeutic UsesIBA
07/2014
1Metformin (Glucophage)FDA LinkGeneric
06/2014
1Hypoglycemic Agents (Hypoglycemics)IBA
06/2014
1lysyl- arginyl- alanyl- lysyl- alanyl- lysyl- threonyl- threonyl- lysyl- lysyl- arginine (PKCS)IBA
06/2014
1Tyrosine Kinase InhibitorsIBA
01/2014
1flavanoneIBA
06/2010
1milk-thistle extractIBA
06/2010
1Antineoplastic Agents (Antineoplastics)IBA
02/2008
12,3-dimethoxycinnamoyl azideIBA
02/2008
1DepsipeptidesIBA
02/2008
1Azacitidine (5 Azacytidine)FDA Link
04/2007

Therapy/Procedure

4Therapeutics
01/2022 - 04/2007
4Lasers (Laser)
01/2021 - 08/2014
3Cystectomy
01/2022 - 12/2019
3Immunotherapy
01/2022 - 01/2021
3Transurethral Resection of Bladder
01/2022 - 08/2014
3Castration
10/2018 - 08/2013
3Drug Therapy (Chemotherapy)
05/2017 - 06/2011
1Semiconductor Lasers
06/2019
1Cystoscopes
01/2017
1Analgesia
01/2015
1Local Anesthesia
01/2015
1Nerve Block (Nerve Blocks)
01/2015
1Solid-State Lasers
08/2014
1Radiotherapy
06/2014
1Adjuvant Radiotherapy
06/2014
1Investigational Therapies (Experimental Therapy)
06/2011